The Hereditary Cancer Testing market is a subset of the Diagnostics industry, focusing on the detection of genetic mutations that can lead to an increased risk of developing certain types of cancer. Tests are typically conducted on a patient's saliva or blood sample, and the results are used to inform decisions about preventative measures, such as increased screening or prophylactic surgery. Hereditary Cancer Testing is a rapidly growing field, with new technologies and tests being developed to detect more mutations and provide more accurate results. Companies in the Hereditary Cancer Testing market include Ambry Genetics, Invitae, Myriad Genetics, Counsyl, and Color Genomics. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
